| 摘要 |
FIELD: medicine. SUBSTANCE: method involves performing superficial epithelium layer coagulation by means of CO2 laser at wavelength of 10.6 mcm, 1 to 10 W power and spot diameter of 300-800 mcm under local anesthesia. Exposure time is 0.1-0.5 s. The number of applications is 4-15. Cornea is then coagulated with infrared laser at 1.54 mcm wavelength, 200 to 800 mJ power and spot diameter of 300-1000 mcm. Exposure time is 1,5.10-3 s. The number of applications is 5-18. One month later, residual hypermetropic astigmatism correction is carried out by means of cornea coagulation in weak meridian contiguous to dystrophy zone using infrared laser at 1.54 mcm wavelength, 200 to 800 mJ power and spot diameter of 300-1000 mcm. Exposure time is 1,5.10-3 s. The number of applications is 5-18. EFFECT: enhanced effectiveness of treatment; reduced amblyopia and squint manifestations; improved binocular vision function.
|
